Erratum: Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial

Aurore Perrot

Thierry Facon

6Department of Hematology, University Hospital and INSERM Unité Mixte de Recherche S1277, Lille, France

Torben Plesner

Saad Z. Usmani

Memorial Sloan Kettering Cancer Center, New York

Shaji Kumar

Nizar J. Bahlis

Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada

Cyrille Hulin

Service d’Hématologie, Hôpital Haut Lévêque, Centre Hospitalier Universitaire (CHU) de Bordeaux, Pessac, France

Robert Z. Orlowski

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Hareth Nahi

Peter Mollee

10Department of Haematology, Princess Alexandra Hospital and University of Queensland, Brisbane, Australia

Karthik Ramasamy

Murielle Roussel

9Department of Hematology, Centre Hospitalo-Universitaire de Limoges, Limoges, France

Arnaud Jaccard

Michel Delforge

Lionel Karlin

Service Hématologie, Hôpital Universitaire Lyon Sud, Pierre-Bénite, France

Bertrand Arnulf

Hôpital Universitaire St. Louis, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris

Ajai Chari

University of California San Francisco, San Francisco, California, United States

Jianming He

Kai Fai Ho

Rian Van Rampelbergh

Clarissa M. Uhlar

Jianping Wang

Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering

Rachel Kobos

Johnson & Johnson, Raritan, NJ

Katharine S. Gries

John Fastenau

Katja Weisel